Submitted by WallStArb on Wed, 01/25/2012 - 12:47pm
Attached is a PDF of most of the small/mid cap biotech and their current cash situation. As a RULE it's unwise to invest in a company that won't be around in the near future or has a dire need to secure financing. Many times it's possible to find companies who's lead product might have failed or had bad data and the stock collapses.
10 yr treasury broke above recent resistance while S&P is teetering just below multi month highs. Any weakness in Europe and US risk assets should lead to a move in the 10yr US treasury 1.75 - 1.80 level.
Submitted by stockmarketcalls on Mon, 01/09/2012 - 8:46am
COPPER (FEB) – Copper’s Nov contract which is going to expire on 29th FEB 2012, is expected to trade between the broad ranges of 398 to 406 Expected resistance and support level for today trade are as follows:
SUPPORT 1: 399.15
SUPPORT 2: 397.35
RESISTANCE 1: 403.55
RESISTANCE 2: 405.10
CRUDE OIL (JAN) – Expected resistance and support levels for the crude Dec contract with expiry date of 19 JAN 2012 are:
SUPPORT 1: 5275
Welcome back to Financial Chat. In case you haven't noticed the site has been disrupted for a few weeks. Over the next few days/weeks we will be rolling out a new site and hope to have it fully functional soon. If you have any questions or concerns feel free to contact us!
